Describing our experience with the effects of multisystem inflammatory syndrome in children with COVID-19 on the...

Area of Science:

• Pediatric Cardiology
• Pediatric Infectious Diseases
• Pediatric Critical Care Medicine

Background:

• Multisystem inflammatory syndrome in children (MIS-C) is a serious condition with potential cardiac complications.
• Cardiac manifestations in MIS-C can range from coronary artery abnormalities to myocarditis and pericarditis.

Purpose of the Study:

• To investigate the specific cardiac findings in pediatric patients diagnosed with MIS-C.
• To evaluate the relationship between biomarkers (BNP, troponin) and cardiac function (ejection fraction) in MIS-C.
• To assess the efficacy of treatments like steroids and IVIG on cardiac recovery in MIS-C.

Main Methods:

• Retrospective analysis of 34 pediatric patients with MIS-C admitted to a single institution.
• Collection of data on patient demographics, cardiac biomarkers (BNP, troponin), ejection fraction, and electrocardiogram findings.
• Assessment of treatment protocols including steroids, Intravenous immune globulin (IVIG), and anakinra.

Main Results:

• Elevated brain natriuretic peptide (BNP) did not reliably predict troponin elevation, and vice versa.
• Troponin elevation was not a consistent indicator of decreased left ventricular ejection fraction.
• All observed cardiac abnormalities were transient and resolved following treatment.

Conclusions:

• Cardiac involvement in MIS-C, while significant, appears to be reversible with appropriate medical intervention.
• Standard biomarkers like BNP and troponin may not fully capture the spectrum of cardiac dysfunction in MIS-C.
• Steroids and IVIG are effective in resolving cardiac manifestations of MIS-C in children.